UnitedHealth Group has remained a subject of active institutional attention heading into mid-2026. The company operates across managed care, pharmacy benefits, and health services segments, and continues to draw scrutiny amid a broader environment of elevated healthcare costs and regulatory developments affecting the managed care sector. No specific briefing-sourced news events are available for this report period beyond the institutional positioning shifts that motivated this publication [Brief - 2026-05-24].
For the trailing twelve months ended 2026-03-31, UnitedHealth Group reported revenue of approximately $449.7 billion, representing year-over-year growth of roughly 1.96%. Net income for the same period stood at approximately $12.8 billion, with a net margin of 2.85% and an operating margin of 4.19%. Earnings per share grew 0.73% year-over-year. The company held $28.0 billion in cash against $77.9 billion in total debt. The current price-to-earnings ratio is 29.16, and market capitalisation stood at approximately $351.7 billion [SEC 10-Q - UNH - 2026-03-31].
Several notable institutional position changes were reported in the most recent 13F filings. Millennium Management added approximately 56% to its UNH position, while AQR Capital increased its holdings by roughly 36%, and Soros Fund Management expanded its stake by 14%. In contrast, Citadel reduced its position by approximately 19%, and Tiger Global trimmed its holding by 17% [SEC 13F - Millennium - Q1 2026] [SEC 13F - AQR Capital - Q1 2026] [SEC 13F - Soros Fund Mgmt - Q1 2026] [SEC 13F - Citadel - Q1 2026] [SEC 13F - Tiger Global - Q1 2026]. No insider transaction data was available for inclusion in this report.
The prevailing macroeconomic backdrop features a 10-year US Treasury yield of 4.57% and a 2-year yield of 4.08%, producing a normal yield curve spread of approximately 49 basis points [FRED DGS10] [FRED DGS2]. These interest rate levels influence UnitedHealth Group's investment income on its substantial float as well as the broader cost of capital environment relevant to its debt obligations and capital allocation decisions.